Top Pharmaceutical Companies (2,036)
TIENS Group is a global multinational conglomerate founded in 1995 by Li Jinyuan in Tianjin, China. The company specializes in biotechnology, health management, and wellness, operating in over 190 countries. It offers a wide range of dietary supplements, healthcare equipment, and beauty products, aiming to improve global health by integrating nature with modern science and technology to provide a better...
Headquartered in Seoul, South Korea, LOTTE BIOLOGICS was founded in 2022 with a mission to deliver therapies that contribute to a healthier world. At the Syracuse Bio Campus in New York, LOTTE BIOLOGICS provides high-quality GMP manufacturing services for drug substances. The facility offers a total production capacity of 40,000L, supported by eight 5,000L stainless steel bioreactors. Additionally, the campus includes...
Nitika Pharmaceutical Specialities Pvt. Ltd. is an India-based pharmaceutical manufacturer and exporter founded in 1991 and headquartered in Nagpur. The company specializes in pharmaceutical excipients, antacid active ingredients, mineral salts, and related formulation materials. Its products support pharmaceutical manufacturing worldwide, with distribution reaching more than 90 countries across regulated and emerging international markets. Nitika emphasizes innovation, quality, patient focus, integrity,...
Galatea Bio is an innovative, venture-backed biotechnology company dedicated to advancing precision health for all. The company leverages world-class ancestry algorithms to better understand underserved Latin American populations while maintaining a strong commitment to ethical research. It partners with pharmaceutical and life sciences organizations to design and execute projects that utilize human genetic diversity to solve acute problems in biomedicine.
Ensera Design is a global healthcare innovation partner and design and product development consultancy specializing in human-centered MedTech, pharmaceutical, and consumer health product design and development. Formed by uniting studios HS Design and Kinneir Dufort, the company provides end-to-end support from initial concept through to commercial manufacturing, delivering safe, effective, and market-ready solutions designed to improve global health outcomes.
Oximio provides global clinical trial logistics and tailored supply chain solutions for complex, multinational clinical studies. It supports pharmaceutical and research organizations with project management, storage and distribution, customs clearance, comparator sourcing, biosample management, temperature-controlled handling, and patient-focused delivery. Its worldwide depot and warehouse network enables compliant movement of investigational medicines and trial materials across international markets from planning through...
We all know someone who's been in the hospital -- a parent, spouse, child, neighbor, coworker or friend. Safecor Health helps hospitals ensure quality and patient safety through superior packaging and bar coding services. Safecor Health is the industry leader committed to providing institutional pharmacists with unit-dose repackaging services that allow them to outsource the challenging and time-consuming tasks of packaging....
Brennan & Co Group is an Ireland-based supplier and service provider of equipment, reagents, consumables, and supply-chain management. Founded in Dublin, the group serves the Life Sciences, Healthcare, Industrial, and Pharmacy sectors across Ireland, Europe, and Asia. It comprises Brennan & Co and three related companies, combining specialized technological products with servicing and supply-chain expertise for customers in technical and...
Viatris is a global pharmaceutical company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer.
Viatris's Top Stability & Growth Strengths
Cost & Operational Efficiency: Cost-savings efforts are positioned as a concrete lever to support improved earnings and fund growth priorities, with an enterprise-wide program targeting substantial savings over multiple years. Guidance frames these actions as part of a broader move toward sustained revenue and earnings improvement beginning in 2026.
Resilient & Sustainable Growth: Growth is presented as re-emerging, with management guiding to a return to modest year-over-year revenue expansion in 2026 after a softer 2025. Improving quarterly trends exiting 2025 and a baseline of modest operational growth excluding divestitures support a narrative of stabilization.
Strong Market Position & Advantage: Scale and global reach are repeatedly highlighted as a stabilizing advantage, with broad geographic coverage and a large portfolio supporting access, supply reach, and competitive standing in off-patent medicines. The strategic shift toward complex generics and specialty brands is framed as reinforcing the company’s long-term positioning against pricing pressures.
We use data to understand what specialty drugs do at the individual, not population level. Our specialty drug management product, VIVIO Precision Care™ fixes big unsolved healthcare problems: expensive drug therapies that don’t work; lack of real-world effectiveness; doctors prescribing based on opinion and experience instead of data; the arbitrary line between pharmacy drug and medical benefit; and, egregious supply...
Pliant Therapeutics is a late-stage clinical company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases We believe that by harnessing the therapeutic potential of integrin biology and TGF-β modulation, there is a potential to create drug candidates aimed at halting or even reversing fibrotic diseases and address the unmet needs of many patients. Pliant’s...
Diffuse Bio is a biotechnology company that leverages generative AI to design and engineer novel protein therapeutics. By developing foundational models and software platforms like DiffuseSandbox and RamaX, the company aims to transition protein design from slow wet-lab workflows to high-precision computational design. Their mission is to create new and useful proteins with unprecedented control and accuracy to accelerate the...
The Parker Institute for Cancer Immunotherapy (PICI) is a nonprofit program and an unprecedented collaboration among the world's leading researchers, doctors, and cancer centers. Its mission is to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases by breaking down entrenched infrastructure barriers and fostering collaboration between researchers, nonprofits, and industry partners.
Arrowhead Pharmaceuticals is a clinical stage, Nasdaq listed (ticker ARWR) company developing medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, our therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism...
Achira is building atomistic foundation simulation models to power the future of drug discovery.
SynX Therapeutics is a pre-seed biotech start-up focused on building the world's fastest lab-in-the-loop platform for drug discovery. They leverage engineered biology, high-throughput experimentation, and AI to enable the ultra-rapid discovery and optimization of non-natural macrocyclic peptide therapeutics.
ISPV Inc. is a Life Science company that leads Productivity & Validation projects for the Pharmaceutical and Food industries.
Xogene provides AI-powered clinical trial transparency solutions and specialist services for biopharmaceutical companies. Its platforms automate and streamline protocol registration, results reporting, plain-language summaries, redaction, anonymization, and regulatory-compliance workflows across global clinical-trial registries. The company also offers advisory, medical-writing, and regulatory-intelligence services, helping sponsors accelerate drug development, make trial data accessible, and focus more resources on patients and caregivers.
Mundipharma is a global healthcare company with a presence across Africa, Asia Pacific, Canada, Europe, Latin America, and the Middle East. Mundipharma is dedicated to bringing innovative treatments to patients in the areas of Pain Management, Infectious Disease and Consumer Healthcare as well as other severe and debilitating disease areas. Our guiding principles, centred around Integrity and Patient-Centricity, are at the heart...
Mundipharma's Top Stability & Growth Strengths
Product Line Growth: Recent approvals and a full asset acquisition for REZZAYO/rezafungin, alongside active Phase 3 work, indicate a broadening portfolio. Lifecycle updates such as a lower‑GWP flutiform MDI reinforce continued product development.
Market Expansion: EU, UK and UAE regulatory clearances and initial availability/reimbursement steps for REZZAYO suggest ongoing rollout into new markets. A multi‑region ex‑U.S. footprint supports selective country‑level leadership in defined niches.
Future-Ready Strategy: The divestment of Consumer Health to focus on prescription specialty care signals a deliberate resource shift toward higher‑value Rx categories. Sustainability initiatives and late‑stage clinical investment point to preparation for evolving market and regulatory expectations.
